InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,648.40
(
1.01%
)
US TECH 100
19,050.40
(
1.19%
)
Dow Jones
41,563.08
(
0.55%
)
Brent Oil
77.00
(
0.00%
)
Bitcoin
59,213.94
(
0.17%
)
Post# of 252997
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Titan V

Send PM Follow Ignore
Followers 31
Posts 3757
Boards Moderated 0
Alias Born 01/29/2012

Titan V

Re: None

Monday, 10/23/2017 4:07:51 PM

Monday, October 23, 2017 4:07:51 PM

Post# of 252997
ICPT Announces Positive Results from Phase 2 AESOP Trial Evaluating OCA for the Treatment of Patients with Primary Sclerosing Cholangitis
https://globenewswire.com/news-release/2017/10/23/1151797/0/en/Intercept-Announces-Positive-Results-from-Phase-2-AESOP-Trial-Evaluating-OCA-for-the-Treatment-of-Patients-with-Primary-Sclerosing-Cholangitis-at-The-Liver-Meeting-2017.html

- OCA met the primary endpoint of alkaline phosphatase (ALP) reduction at 24 weeks
- Results presented in a late-breaking oral session
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up